Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
PURITAN MEDICAL
FOCUS DIAGNOSTICS, INC.

Blood Urea and Creatinine Stability Determined for Chemistry Analyzer

By Labmedica International staff writers
Posted on 17 Dec 2013
Advia 1800 Chemistry Analyzer System (Photo courtesy of Siemens).
Advia 1800 Chemistry Analyzer System (Photo courtesy of Siemens).
Serum creatinine values of patients tend to change as a result of the use of different blanks used for creatinine determinations on some clinical chemistry analyzers.

A general quality assurance program in clinical chemistry laboratories is an essential part of monitoring the stabilities of determinations on what are commonly known as stat analytes, including sodium, potassium, chloride, bicarbonate, calcium, glucose, blood urea nitrogen (BUN), and creatinine.

Medical laboratory scientists at the New York Harbor Veteran Affairs Medical Center (Brooklyn, NY, USA) investigated the reproducibility of creatinine values, by determining the serial creatinine values in the sera of 13 patients whose initial values were either in the reference range or elevated (range 0.58 to 7.8 mg/dL). They determined BUN and creatinine values, using the glutamate dehydrogenase linked enzyme assay system and the Jaffe method, respectively.

Determination of all values was performed on the Siemens Advia 1800 chemistry analyzer (Siemens Healthcare; Tarrytown, NY, USA) using the method for creatinine, which uses the formation of a complex of creatinine with picric acid, and for BUN values urease-catalyzed release of ammonia was measured by the glutamate dehydrogenase system. The creatinine values were determined concurrently with serum blood urea nitrogen (BUN) determinations, range 6.0 to 84.4 mg/dL, as these two analytes are used together in evaluation of renal function.

The scientists found that all values for creatinine on samples stored at 4 °C were reproducible as were the corresponding BUN values, which is revealed by low values for the coefficients of variation (CV). One sample with relatively high CV of 10.6% for creatinine was found to have an initial value of 1.1 mg/dL, in the reference range; but, on repeat determinations, the obtained levels were as high as 1.5 mg/dL, above the reference range. BUN values for this sample remained in the reference range, suggesting that no renal disease was present.

The authors concluded that the precision of the serum BUN assays on the Advia 1800 analyzer is quite high over the prolonged time period of 15 days. The same conclusion applies to serum creatinine assay results on this analyzer with the caveat that borderline values can show less precision-making evaluation of renal function more difficult. The study was published on November 11, 2013, in the Journal of Clinical Laboratory Analysis.

Related Links:

New York Harbor Veteran Affairs Medical Center
Siemens Healthcare

CELLAVISION AB
77 ELEKTRONIKA
KARL HECHT GMBH & CO KG

Channels

Genetic Tests

view channel
Image: Histopathology of a coronary artery with the most common form of obstructive coronary artery disease (atherosclerosis) and marked luminal narrowing (Photo courtesy of Nephron).

Blood Test Influences Clinical Decisions in Coronary Artery Disease

Clinicians need better approaches to evaluating women at midlife and beyond who present to primary care with chest pain and related symptoms such as an individual's current likelihood of having obstructive... Read more

Microbiology

view channel
Image: The Mini-FLOTAC device for examining stool samples for helminths (Photo courtesy of Public Health Laboratory Ivo de Carneri).

Device Diagnostics of Fixed Soil-Transmitted Helminth Infection Assessed

Kato-Katz is a widely used method for the diagnosis of soil-transmitted helminth infection, but fecal samples cannot be preserved, and hence, should be processed on the day of collection and examined under... Read more

Industry News

view channel
Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).

Partnership to Offer New Coagulation Testing Solutions Worldwide

Abbott (Abbott Park, IL, USA) and Sekisui Diagnostics LLC (Lexington, MA, USA), a sister company of Sekisui Medical (SMD; Tokyo, Japan ), have entered an agreement to offer new coagulation testing solutions... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.